MedTrace Logo

The Impact of Glycemic Index Education on Lowering Dietary GI in Gestational Diabetes Mellitus

NCT04272840 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-03-31

No results posted yet for this study

Summary

Gestational Diabetes Mellitus (GDM) incidence is increasing worldwide, and within Canada, the Atlantic provinces statistically have been found to have highest prevalence of diabetes. Increasing evidence supports the benefit of following a low glycaemic index (GI) diet in GDM and the Canadian Diabetes Guidelines recommends replacing high GI foods for low GI foods. Despite recommendation to adapt a low GI diet in GDM, there are limitations and barriers recognized to GI utility largely focused on knowledge translation. There is sufficient research to support a low GI diet in benefiting outcomes of GDM, therefore the GI in GDM Online trial will investigate the feasibility and effectiveness of a distance low GI education intervention, adapted from Diabetes Canada's GI materials, on producing a difference in average dietary GI between a group with the intervention and standard care.

Conditions

  • Gestational Diabetes Mellitus

Interventions

BEHAVIORAL

Low Glycemic Index Education

Educational materials layering Glycemic Index education onto Canada's Food Guide and Diabetes Canada recommendations.

Sponsors & Collaborators

  • Mount Saint Vincent University

    collaborator OTHER

  • Dalhousie University

    collaborator OTHER

  • The Hospital for Sick Children

    collaborator OTHER

  • IWK Health Centre

    lead OTHER

Principal Investigators

  • Shannan Grant, PhD, PDt · IWK Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-24
Primary Completion
2022-05-31
Completion
2022-08-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04272840 on ClinicalTrials.gov